View Post

What You Need to Know About Breast Cancer Chemotherapy Pills

In In The News by Barbara Jacoby

From: healthline.com People commonly associate chemotherapy with intravenous (IV) cancer drugs in a hospital or doctor’s office. This has been the traditional nonsurgical method of treating cancer. Due to recent advances in cancer treatments, oral chemotherapy pills have become more widely used for many types of cancer. There are a few that are approved for breast cancer, including capecitabine (Xeloda), …

View Post

Value-Based Decision-Making in Metastatic Breast Cancer

In In The News by Barbara Jacoby

From: managedhealthcareexecutive.com In this Managed Healthcare Executive® KCast, Ian Krop, M.D., Ph.D., oncologist and associate professor of medicine at Dana-Farber Cancer Institute in Boston, and Debra Patt, M.D., Ph.D., MBA, executive vice president at Texas Oncology in Austin, provide key insights into the value-based care model for patients with HER2-positive metastatic breast cancer (mBC). This article summarizes the highlights of …

View Post

Carrick Therapeutics Presents Encouraging Initial Efficacy for Samuraciclib (CT-7001) in Combination with Fulvestrant in Advanced HR+, HER2- Breast Cancer Patients at ESMO Congress 2021

In In The News by Barbara Jacoby

From: biospace.com Phase 2a Tolerability and Efficacy Data Supports Further Clinical Development of Samuraciclib in Combination with Fulvestrant in HR+, HER2- Breast Cancer Previously Treated with a CDK4/6 Inhibitor Carrick Therapeutics, an oncology-focused biopharmaceutical company discovering and developing highly differentiated therapies, today presented encouraging initial clinical data on samuraciclib (CT-7001), an oral and first-in-class inhibitor of CDK7, at the 2021 …

View Post

Study identifies possible link between antibiotic use and breast cancer growth

In In The News by Barbara Jacoby

By: Darcy Jimenez From: pharmaceutical-technology.com New research has uncovered a possible link between antibiotic use and the speed of breast cancer growth in mice, and identified an immune cell that could be used to reverse the effect. The study, funded by Breast Cancer Now and conducted by scientists from the Quadram Institute and the University of East Anglia (UEA), involved …

View Post

IceCure Medical Announces First Peer Reviewed Publication for the 3-Year Interim Analysis of the ICE3 Trial on Cryoablation of Low-Risk, Early-Stage Breast Cance

In In The News by Barbara Jacoby

Source: IceCure Medical From: prnewswire.com IceCure Medical Ltd. (NASDAQ: ICCM) (TASE: ICCM) (“IceCure” or the “Company”), developer of the next generation minimally invasive cryoablation technology that destroys tumors by freezing, today announced that the first peer reviewed article “Cryoablation Without Excision for Low-Risk, Early-Stage Breast Cancer: 3-Year Interim Analysis of Ipsilateral Breast Tumor Recurrence in the ICE3 Trial” was published in the …

View Post

Antipsychotics Tied to Increased Breast Cancer Risk

In In The News by Barbara Jacoby

By: Batya Swift Yasgur, MA, LS From: medscape.com Use of antipsychotics that increase prolectin levels is significantly associated with an increased risk for breast cancer in women with schizophrenia, new research suggests. However, at least one expert says that at this point, clinical implications are premature. Investigators compared data from Finnish nationwide registers on more than 30,000 women diagnosed with …

View Post

Challenges in the Multidisciplinary Management of Breast Cancer

In In The News by Barbara Jacoby

From: onclive.com Key opinion leaders highlight the challenges inherent in using multidisciplinary care to manage breast cancer, particularly when a patient is seen at multiple institutions. Joyce A. O’Shaughnessy, MD: A particular challenge is when patients are hospitalized. They oftentimes are at an outside institution, and you may not even know they’re hospitalized for a day or 2. Of course, …

View Post

Legislation may help identify breast cancer earlier in certain at-risk women

In In The News by Barbara Jacoby

By: Zachary Sweger From: psu.edu Laws designed to help women with increased risk for missed breast cancer diagnoses may help catch the disease earlier, according to Penn State College of Medicine researchers. They studied how notification and insurance coverage legislation for women with dense breast tissue affects the stage at which their cancer is diagnosed. More than 40% of women …

View Post

Can Scalp Cooling Prevent Hair Loss?

In In The News by Barbara Jacoby

From: healthline.com By limiting blood flow to the scalp, cooling can protect your hair follicles from the effects of chemo drugs. Learn more about how it works and how much it costs. Scalp cooling is done by applying cold temperatures to your scalp during chemotherapy treatment for cancer. It’s sometimes called scalp hypothermia. Scalp cooling is intended to help prevent …

View Post

What Is Cording?

In In The News by Barbara Jacoby

From: webmd.com Cording – also known as axillary web syndrome (AWS) – is a side effect of having lymph nodes removed as a result of breast cancer. A cord, or web of cords, develops under the skin on the inside of your arm. This rope-like tissue can be uncomfortable and make it difficult to use your arm normally, but there are …